Published online before print
December 20, 2006, 10.1183/09031936.00086306
Eur Respir J 2007; 29:643-650
Copyright ©ERS Journals Ltd 2007
Mitochondrial dysfunction in COPD patients with low body mass index
R. A. Rabinovich1,2,
R. Bastos1,2,
E. Ardite1,
L. Llinàs1,
M. Orozco-Levi3,4,
J. Gea3,4,
J. Vilaró5,
J. A. Barberà1,
R. Rodríguez-Roisin1,
J. C. Fernández-Checa6 and
J. Roca1
1 Pneumology Service (ICT), Hospital Clinic, and 6 Liver Unit (IMD)-CSIC, IDIBAPS, Barcelona University, 3 Muscle and Respiratory System Research Unit, IMIM, CEXS, Pompeu Fabra University, 4 Respiratory Medicine Department, Hospital del Mar, and 5 EUIF Blanquerna, Ramon Llull University, Barcelona, Spain., and 2 R.A. Rabinovich and R. Bastos contributed equally to the study.
CORRESPONDENCE: R. A. Rabinovich, ELEGI Laboratory, Centre for Inflammation Research MRC/University of Edinburgh 47 Little France Crescent, Edinburgh EH16 4TJ, UK. Fax: 44 1312426582. E-mail: roberto.rabinovich{at}ed.ac.uk
Keywords: Endurance training, glutathione, mitochondrial respiration, muscle dysfunction
Received: June 30, 2006
Accepted December 10, 2006
Patients with chronic obstructive pulmonary disease (COPD) show abnormal adaptations of skeletal muscle redox status after exercise training. Increased skeletal muscle oxidative stress in COPD patients may prompt mitochondrial dysfunction.
The present study explores the association between body composition and mitochondrial respiration in seven COPD patients with low body mass index (BMIL), eight COPD patients with normal body mass index (BMIN) and seven healthy controls. All of them underwent a vastus lateralis biopsy in which muscle structure, in vitro mitochondrial respiratory function, uncoupling protein 3 (UCP3) mRNA expression and glutathione levels in both isolated mitochondria and the whole muscle were determined.
Mitochondrial respiratory function (assessed by acceptor control ratio (ACR)) was impaired in BMIL (2.2±0.6) compared with both BMIN (5.3±1.3) and controls (8.2±1.3). ACR significantly correlated with arterial oxygen tension and with muscle endurance but it showed a negative association with exercise-induced increase in blood lactate levels. UCP3 mRNA expression was reduced in BMIL patients.
In conclusion, chronic obstructive pulmonary disease patients with low body mass index show electron transport chain dysfunction, which may contribute to low muscle endurance in the current subgroup of patients.
This article has been cited by other articles:

|
 |

|
 |
 
M. van der Toorn, D. Rezayat, H. F. Kauffman, S. J. L. Bakker, R. O. B. Gans, G. H. Koeter, A. M. K. Choi, A. J. M. van Oosterhout, and D.-J. Slebos
Lipid-soluble components in cigarette smoke induce mitochondrial production of reactive oxygen species in lung epithelial cells
Am J Physiol Lung Cell Mol Physiol,
July 1, 2009;
297(1):
L109 - L114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Puente-Maestu, J. Perez-Parra, R. Godoy, N. Moreno, A. Tejedor, F. Gonzalez-Aragoneses, J-L. Bravo, F. Villar Alvarez, S. Camano, and A. Agusti
Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients
Eur. Respir. J.,
May 1, 2009;
33(5):
1045 - 1052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Barreiro, R Rabinovich, J Marin-Corral, J A Barbera, J Gea, and J Roca
Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD
Thorax,
January 1, 2009;
64(1):
13 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Picard, R. Godin, M. Sinnreich, J. Baril, J. Bourbeau, H. Perrault, T. Taivassalo, and Y. Burelle
The Mitochondrial Phenotype of Peripheral Muscle in Chronic Obstructive Pulmonary Disease: Disuse or Dysfunction?
Am. J. Respir. Crit. Care Med.,
November 15, 2008;
178(10):
1040 - 1047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M A Spruit, H J Pennings, J D Does, G M Moller, P P Janssen, and E F M Wouters
Serum LDH and exercise capacity in COPD
Thorax,
May 1, 2008;
63(5):
472 - 472.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2007
Am. J. Respir. Crit. Care Med.,
April 15, 2008;
177(8):
820 - 829.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Remels, H. R. Gosker, P. Schrauwen, R. C. Langen, and A. M. Schols
Peroxisome proliferator-activated receptors: a therapeutic target in COPD?
Eur. Respir. J.,
March 1, 2008;
31(3):
502 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D-J. Slebos, M. van der Toorn, S. J. L. Bakker, and H. F. Kauffman
Mitochondrial dysfunction in COPD patients with low body mass index
Eur. Respir. J.,
September 1, 2007;
30(3):
600 - 600.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Rabinovich, R. Bastos, E. Ardite, L. Llinas, M. Orozco-Levi, J. Gea, J. Vilaro, J. A. Barbera, R. Rodriguez-Roisin, J. C. Fernandez-Checa, et al.
From the authors
Eur. Respir. J.,
September 1, 2007;
30(3):
600 - 601.
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the European Respiratory Society.
|